KEGG icon

Drug interaction list


Query:
D10366  Sofosbuvir (JAN/USAN/INN); Sovaldi (TN)

Interactions: 36 hits    [ ATC classification | Therapeutic category ]

D00211  Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) (CI) Transporter induction: ABCB1
D00276  Clarithromycin (JP18/USP/INN); Biaxin (TN) (P) Transporter inhibition: ABCB1
D00506  Phenobarbital (JP18/USP/INN); Luminal (TN) (P) unclassified
D00512  Phenytoin (JP18/USP/INN); Dilantin (TN) (CI,P) Transporter induction: ABCB1
D00701  Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) (P) unclassified
D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) (CI,P) Transporter induction: ABCB1
D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) (P) unclassified
D04641  Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) (P) Transporter inhibition: ABCB1
D04768  Lonafarnib (JAN/USAN/INN); Zokinvy (TN) (P) unclassified
D06407  Vandetanib (JAN/USAN/INN); Caprelsa (TN) (P) Transporter inhibition: ABCB1
D07583  Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) (CI,P) Transporter induction: ABCB1
D07595  Fosphenytoin sodium hydrate (JAN); Fostoin (TN) (CI,P) Transporter induction: ABCB1
D09673  Tafamidis (JAN/USAN/INN); Vyndamax (TN); Vynmac (TN) (P) unclassified
D09674  Tafamidis meglumine (JAN/USAN); Vyndaqel (TN) (P) unclassified
D09686  Tedizolid phosphate (JAN/USAN); Torezolid phosphate; Sivextro (TN) (P) unclassified
D09894  Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) (P) unclassified
D09996  Vemurafenib (JAN/USAN/INN); Zelboraf (TN) (P) Transporter inhibition: ABCB1
D10137  Regorafenib hydrate (JAN); Stivarga (TN) (P) unclassified
D10424  Lasmiditan succinate (JAN/USAN); lasmiditan hemisuccinate; Reyvow (TN) (P) unclassified
D10519  Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) (P) Transporter inhibition: ABCB1
D10643  Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) (P) Transporter inhibition: ABCB1
D10679  Venetoclax (JAN/USAN/INN); Venclexta (TN) (P) unclassified
D10766  Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) (P) Transporter inhibition: ABCG2
D10775  Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) (P) Transporter inhibition: ABCB1
D10891  Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) (P) unclassified
D10999  Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) (P) unclassified
D11012  Lorlatinib (JAN/USAN/INN); Lorbrena (TN) (P) Transporter induction: ABCB1
D11040  Apalutamide (JAN/INN); Erleada (TN) (P) Transporter induction: ABCB1 ABCG2
D11053  Encorafenib (JAN/USAN/INN); Braftovi (TN) (P) unclassified
D11073  Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN); Tepmetko (TN) (P) unclassified
D11078  Vadadustat (JAN/USAN/INN); Vafseo (TN) (P) unclassified
D11400  Abrocitinib (JAN/USAN); Cibinqo (TN) (P) unclassified
D11641  Danicopan (JAN/USAN/INN); Voydeya (TN) (P) unclassified
D11662  Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) (P) unclassified
D11725  Futibatinib (JAN/USAN/INN); Lytgobi (TN) (P) unclassified
D12055  Sotorasib (JAN/USAN); Lumakras (TN) (P) unclassified